Bio-Techne (TECH) Operating Margin (2009 - 2026)
Bio-Techne's quarterly Operating Margin came in at 24.24% in Q1 2026, up 1200.0% year-on-year from 1.86% in Q1 2025, and up 31.71% quarter-over-quarter from 18.41% in Q4 2025.
Bio-Techne has reported Operating Margin for 18 years, with the latest figure at 24.24% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 1200.0% year-over-year to 24.24%; the trailing twelve-month figure through Mar 2026 stood at 12.7% (down 153.0% YoY), and the FY2025 full-year result was 8.38%, down 945.0% from the prior year.
- Operating Margin for Q1 2026 stood at 24.24%, up from 18.41% in the prior quarter.
- The five-year high for Operating Margin was 2815.85% in Q3 2022, with the low at 7.53% in Q2 2025.
- Average Operating Margin over 5 years is 183.74%, with a median of 20.17% recorded in 2023.
- Year-over-year, Operating Margin surged 279132 bps in 2022 and slumped 279568 bps in 2023.
- Tracing TECH's Operating Margin over 5 years: stood at 25.0% in 2022, then sank by 44 bps to 13.94% in 2023, then increased by 15 bps to 15.96% in 2024, then rose by 15 bps to 18.41% in 2025, then soared by 32 bps to 24.24% in 2026.
- The last three Operating Margin figures came in at 24.24% (Q1 2026), 18.41% (Q4 2025), and 16.63% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 24.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24% |
| Dec 31, 2025 | 18.41% |
| Sep 30, 2025 | 16.63% |
| Jun 30, 2025 | -7.53% |
| Mar 31, 2025 | 12.24% |
| Dec 31, 2024 | 15.96% |
| Sep 30, 2024 | 13.81% |
| Jun 30, 2024 | 14.97% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | 13.94% |
| Sep 30, 2023 | 20.17% |
| Jun 30, 2023 | 31.37% |
| Mar 31, 2023 | 27.27% |
| Dec 31, 2022 | 25.00% |
| Sep 30, 2022 | 2,815.85% |
| Jun 30, 2022 | 27.95% |
| Mar 31, 2022 | 31.15% |
| Dec 31, 2021 | 23.15% |
| Sep 30, 2021 | 24.53% |
| Jun 30, 2021 | 26.48% |
| Mar 31, 2021 | 28.18% |
| Dec 31, 2020 | 22.74% |
| Sep 30, 2020 | 24.04% |
| Jun 30, 2020 | 22.36% |
| Mar 31, 2020 | 24.55% |
| Dec 31, 2019 | 20.00% |
| Sep 30, 2019 | 18.19% |
| Jun 30, 2019 | 22.57% |
| Mar 31, 2019 | 23.85% |
| Dec 31, 2018 | 19.26% |
| Sep 30, 2018 | 15.81% |
| Jun 30, 2018 | 23.81% |
| Mar 31, 2018 | 26.28% |
| Dec 31, 2017 | 15.66% |
| Sep 30, 2017 | 18.00% |
| Jun 30, 2017 | 25.58% |
| Mar 31, 2017 | 23.26% |
| Dec 31, 2016 | 13.57% |
| Sep 30, 2016 | 22.33% |
| Jun 30, 2016 | 29.69% |
| Mar 31, 2016 | 33.23% |
| Dec 31, 2015 | 29.80% |
| Sep 30, 2015 | 27.61% |
| Jun 30, 2015 | 32.13% |
| Mar 31, 2015 | 34.54% |
| Dec 31, 2014 | 30.89% |
| Sep 30, 2014 | 32.46% |
| Jun 30, 2014 | 41.99% |
| Mar 31, 2014 | 47.90% |
| Dec 31, 2013 | 42.54% |
| Sep 30, 2013 | 45.98% |
| Jun 30, 2013 | -78.54% |
| Mar 31, 2013 | 54.26% |
| Dec 31, 2012 | 49.15% |
| Sep 30, 2012 | 50.39% |
| Jun 30, 2012 | 52.39% |
| Mar 31, 2012 | 55.44% |
| Dec 31, 2011 | 50.47% |
| Sep 30, 2011 | 52.77% |
| Jun 30, 2011 | 54.59% |
| Mar 31, 2011 | 58.66% |
| Dec 31, 2010 | 55.16% |
| Sep 30, 2010 | 56.46% |
| Jun 30, 2010 | -93.90% |
| Mar 31, 2010 | 59.26% |
| Dec 31, 2009 | 55.79% |
| Sep 30, 2009 | 58.92% |